Sterling Shepard

Wide Receiver

Age: 31
Free Agency: 2024 (UFA)
Accrued Seasons: 8
  • 2024 Salary Cap Charge: $0 (0.00% of cap)
  • 2024 Cash Payout: $0 (0.00% of spending)
  • 2024 Cash to Cap Ratio: 0
  • Contract Value: $1,317,500 ($1,317,500 APY)
  • Fully Guaranteed Money: $0
  • Contract Ranking: 100/299 at WR

Current Contract

(UFA, signed 2023)
(📝: indicates contract trigger occuring during that year)
YearAgeBase SalaryPer Game Roster BonusCap
Number
Cap %
Dead Money & Cap Savings
202330$1,165,000$152,500$1,092,5000.5%
Total$1,165,000$152,500$1,092,500

Contract Notes

Sterling Shepard signed a four year, $41 million contract with the Giants on April 12, 2019. Shepard received $21.26 million in guarantees of which $16.21 million is fully guaranteed at signing. The full guarantee on the contract is made up of a $10 million signing bonus, his 2019 base salary, and $5.45 million of his 2020 base salary. The other salary, which is injury protected, will vest to a full guarantee on the 3rd day of the 2020 and 2021 league years. There is also $100,000 in workout bonuses due during the life of the contract.

Cash Flows

- fully earned money
- unearned or partially earned money
$1.3M
2023
Cash Due$1,317,500
Running Cash$1,317,500
Career Earnings: $32,644,425
Career APY: $4,080,553
Potential Earnings: $32,644,425
Total Guarantees: $18,210,624
Largest Cash Payment: $10,760,624 (2019)
Largest Cap Number: $8,500,000 (2020)

Contract History

TeamContract TypeStatusYear SignedYrsTotalAPYGuaranteesAmount Earned% EarnedEffective APY
GiantsDraftedRenegotiated20164$5,944,572$1,486,143$0$4,683,94878.8%$1,561,316
GiantsExtensionRenegotiated20194$41,000,000$10,250,000$16,210,624$24,260,62459.2%$8,086,875
GiantsOtherExpired20222$3,000,000$3,000,000$2,000,000$2,382,35379.4%$2,382,353
GiantsUFAActive20231$1,317,500$1,317,500$0$1,317,500100.0%$1,317,500
Earnings By Team
TeamYrsSalaryAPYPaid on Cap% Paid on CapPaid as Dead Money% Paid as Dead Money
Giants8$32,644,425$4,080,553$28,350,8960.0%$4,245,0000.0%

Season History

YearTeamBase SalaryProrated BonusPer Game Roster BonusWorkout BonusGuaranteed SalaryCap
Number
Cap %Cash Paid
2016Giants$450,000$630,831$0$0$450,000$1,080,8310.7%$2,973,324
2017Giants$720,208$630,831$0$0$720,208$1,351,0390.8%$720,208
2018Giants$990,416$630,831$0$0$0$1,621,2470.9%$990,416
2019Giants$760,624$2,630,831$0$0$760,624$3,391,4551.7%$10,760,624
2020Giants$6,475,000$2,000,000$0$25,000$6,475,000$8,500,0004.3%$6,500,000
2021Giants$990,000$3,995,000$0$25,000$990,000$5,010,0002.7%$7,000,000
2022Giants$1,500,000$4,245,000$750,000$250,000$0$6,303,8243.0%$2,382,353
2023Giants$1,165,000$0$152,500$0$0$1,092,5000.5%$1,317,500
Total$13,051,248$14,763,324$902,500$300,000$9,395,832$28,350,896$32,644,425
Dead Money History
TeamYearCap ChargeCash Paid
Giants2023$4,245,000$0
Total$4,245,000$0

Statistics

YearGames PlayedGames InactiveSnapsRushingReceivingFumbles
InjuredHealthyOffenseSpecialAttYardsAvgTDRecYardsAvgTDTotalLost
2016160094.7%0.2%33110.306568310.5800
2017114163.4%0.0%441.005973112.4210
2018160090.8%2.0%33311.006687213.2410
2019105156.2%0.2%67212.005757610.1300
2020120055.4%0.2%6498.21666569.9300
202177031.2%0.0%1-9-9.003636610.2100
202230014.5%0.0%000.001315411.8100
2023150012.9%1.5%166.0010575.7100

Valuation Diamond

The diamond is a scatterplot graph that visualizes the relation of the player's APY (in green) and performance (in blue, as measured by OTC's Valuations) to the rest of the league at his position. To understand how to read the diamond, read this explainer.

OTC ValuationAPY
Regular$315,000$1,317,500
Injury Adjusted$315,000$1,317,500
test
OTC Valuation $4.3M $8.7M $13M $17.4M $21.7M APY $5M $10M $15M $20M $25M $9,208,000 $5,035,348

Weekly Valuation Trends

The chart below illustrates the trend of the player's weekly OTC Valuations (in blue) from the most recent season, using APY (in green) and, if applicable, cash that is due to the player in the next season (in red) as benchmarks. Weeks not plotted indicate that the player was inactive or on a bye.

To see interactive and more in-depth use of OTC Valuation data, subscribe to OTC Premium.